Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome

Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome

Abstract Diffuse gliomas are classified according to the 2016 WHO Classification of Tumors of the Central Nervous System, which now defines entities by both histology and molecular features. Somatostatin receptor subtype 2A (SSTR2A) expression has been reported in various solid tumors as associated...

Full description

Bibliographic Details
Main Authors: Romain Appay, Emeline Tabouret, Mehdi Touat, Catherine Carpentier, Carole Colin, François Ducray, Ahmed Idbaih, Karima Mokhtari, Emmanuelle Uro-Coste, Caroline Dehais, Dominique Figarella-Branger, the POLA network
Format: Article
Language:English
Published: BMC 2018-09-01
Series:Acta Neuropathologica Communications
Subjects:
Somatostatin receptor subtype 2A (SSTR2A)
Glioma
Biomarker
Therapeutic target
Online Access:http://link.springer.com/article/10.1186/s40478-018-0594-1

Internet

http://link.springer.com/article/10.1186/s40478-018-0594-1

Similar Items